The dual-target intervention resulted in highly significant reduction of both VEGF and CTGF transcripts in diabetic retinas ( Figure 6A,B ).
← all excerpts
Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes.
1
—
—